201 related articles for article (PubMed ID: 19412008)
1. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
Socha P; Horvath A; Vajro P; Dziechciarz P; Dhawan A; Szajewska H
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):587-96. PubMed ID: 19412008
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
3. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
4. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
[TBL] [Abstract][Full Text] [Related]
5. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
[TBL] [Abstract][Full Text] [Related]
7. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
Kadayifci A; Merriman RB
Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968
[No Abstract] [Full Text] [Related]
8. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
Sanyal AJ; Mofrad PS; Contos MJ; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Clore J; Mills AS
Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1107-15. PubMed ID: 15625656
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Sanyal AJ; Chalasani N; Kowdley KV; McCullough A; Diehl AM; Bass NM; Neuschwander-Tetri BA; Lavine JE; Tonascia J; Unalp A; Van Natta M; Clark J; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
N Engl J Med; 2010 May; 362(18):1675-85. PubMed ID: 20427778
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
Patton HM; Lavine JE; Van Natta ML; Schwimmer JB; Kleiner D; Molleston J;
Gastroenterology; 2008 Dec; 135(6):1961-1971.e2. PubMed ID: 19013463
[TBL] [Abstract][Full Text] [Related]
14. Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
Adams LA; Angulo P
Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1059-60. PubMed ID: 15625648
[No Abstract] [Full Text] [Related]
15. Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.
Khoshbaten M; Beheshtirouy S; Shayanrad S; Gharekhani A; Rezaee H
Drug Res (Stuttg); 2023 Apr; 73(4):232-237. PubMed ID: 36791804
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
Said A; Akhter A
Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
[TBL] [Abstract][Full Text] [Related]
17. Review article: Drug therapy for non-alcoholic fatty liver disease.
Comar KM; Sterling RK
Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
Lavine JE; Schwimmer JB; Molleston JP; Scheimann AO; Murray KF; Abrams SH; Rosenthal P; Sanyal AJ; Robuck PR; Brunt EM; Unalp A; Tonascia J;
Contemp Clin Trials; 2010 Jan; 31(1):62-70. PubMed ID: 19761871
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V
Eur J Gastroenterol Hepatol; 2019 May; 31(5):613-617. PubMed ID: 30920975
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
